Impact of the New Administration: HHS, FDA, CMS et al.


February 19, 2021: Advances in Behavioral/Mental Health Treatments

Time   Event
9:30-9:45amWelcome and Introduction
George Telthorst, Director, Center for the Business of Life Sciences, IU-Kelley School of Business
9:45-10:30amKeynote- On the Cutting Edge of Brain Research
William Hetrick, PhD, Professor & Chair, Department of Psychological and Brain Sciences, Indiana University
10:30 – 10:45amBreak
10:45am – 12:15 pmPanel – The Latest Approaches & What’s Next
Moderator: Jennifer Kowalski, Vice President, Public Policy Institute, Anthem

Rob Conley, MD, Chief Science Officer, Neuroscience Development, Eli Lilly and Company
Alison Darcy, PhD, Founder & President, Woebot Health
Melanie Gareau, PhD, Associate Professor, School of Veterinary Medicine, University of California, Davis
Trisha Palencer, LCSW, LCAC, TTS, Director, Addiction Treatment and Recovery Center, IU Health West Hospital
12:15 – 12:30 pmBreak
12:30-1:30 pmBreakout Sessions Over Lunch with the morning speakers
1:30-2:45 pmFireside Chat - The Effects of the COVID-19 Pandemic
Moderator: Kevin Woodhouse, Partner, Ice Miller LLP

Susan Coakley, JD, Interim President, Beacon Health Options
Geoffrey Fortner, MD, Physician Executive, Community Fairbanks Behavioral Health, Community Health Network
Jay Chaudhary, JD, Director, Division of Mental Health and Addiction, Indiana Family and Social Services Administration
2:45 – 3:00pmWrap-up
George Telthorst, Director, Center for the Business of Life Sciences